Navigation Links
A*STAR scientists discover 'switch' to boost anti-viral response to fight infectious diseases
Date:5/11/2012

Singapore scientists from Bioprocessing Technology Institute (BTI) under the Agency of Science, Technology and Research (A*STAR) have for the first time, identified the molecular 'switch' that directly triggers the body's first line of defence against pathogens, more accurately known as the body's "innate immunity". The scientists found that this 'switch' called Bruton's tyrosine kinase (BTK) when turned on, activates the production of interferons - a potent class of virus killers that enables the body to fight harmful pathogens such as dengue and influenza viruses.

While there are anti-viral drugs to treat influenza, the high rates of mutation that are characteristic of the influenza [1] virus have made it difficult to treat with one universal drug or vaccine. As for dengue [2], there are currently no clinically approved vaccines or cures either. This discovery of BTK's role as a critical 'switch' that boosts the body's anti-viral response, paves the way for developing anti-viral drugs that target the BTK 'switch' to fight infectious diseases.

To investigate the role of BTK in innate immunity, the research team from BTI extracted a class of innate immune cells known as macrophages [3] from both normal mice and from mice deficient in BTK and challenged them with the dengue virus. They found that the BTK-deficient immune cells were unable to produce interferons, and hence had much higher viral counts compared to the healthy immune cells that had high-levels of interferons to fight the virus effectively.

To further demonstrate the critical role of BTK in anti-viral response, the team focussed on BTK's role in Toll-like Receptor 3 (TLR3) signaling. TLR3 is needed for cells to activate the interferon response when cells are infected by viruses. The team examined the effect of having a perpetually-"on" or -"off" BTK 'switch' in TLR3 signaling. They uncovered that a constitutively active or "on" BTK 'switch' enhanced the production of interferon, resulting in a stronger and more lasting anti-viral response with significant reduction in Dengue viral counts. In contrast, a perpetually "off" BTK 'switch' led to a poor anti-viral response with very low levels of inteferons produced, and little protection against Dengue virus infection.

Previously, scientists have always thought that BTK is important primarily in antibody production due to observations made of an inherited genetic disorder in humans called X-linked Agammaglobulinemia (XLA). These patients do not have a functional BTK 'switch', and are unable to produce antibodies because defects in BTK cripple maturation of B cells, a type of white blood cell that produces antibodies.

"We are very excited because this is the first time that the link between BTK and its critical role in the immediate anti-viral responses of the immune system, triggered in response to invading viruses like Dengue, is definitively demonstrated", said Dr. Koon-Guan Lee, the first author of this paper.

Said Professor Kong-Peng Lam, Acting Executive Director of BTI and the Head of the Immunology Group that conducted the research, "This study adds new insights to the understanding of how the body's innate immunity is triggered to create an effective immune response. It is a prime example of how better understanding in basic biological systems brings us a step closer to understanding the mechanism of human diseases, and enables us to find more effective treatment strategies to combat deadly viral diseases, which we have yet to find cures for."


'/>"/>
Contact: Dr. Sarah Chang KC
chang_kai_chen@a-star.edu.sg
65-682-66442
Agency for Science, Technology and Research (A*STAR), Singapore
Source:Eurekalert

Related medicine news :

1. A*STAR scientists discover special class of natural fats stimulates immune cells to fight diseases
2. A*STAR scientists make headway for cancer treatment and cancer prevention with landmark discovery
3. NTU and A*STAR launch joint Ph.D. research program in immunology
4. A*STAR and Institut Merieux/bioMerieux invest S$3m ($2.2m) in tuberculosis research
5. A*STAR scientist receives international award for innovation in healthcare technology
6. Scientists Map Melanomas Genome
7. Scripps Research scientists show how memory B cells stay in class to fight different infections
8. Joslin scientists identify important mechanism that affects the aging process
9. NIH scientists link quickly spreading gene to Asian MRSA epidemic
10. Warwick scientists uncover how checkpoint proteins bind chromosomes
11. Scientists rewrite rulebook on breast cancer in landmark global study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... the "Structural Electronics 2015-2025: Applications, Technologies, Forecasts" ... In-Mold Electronics, Smart Skin, Structural ... Structural electronics involves electronic and/or ... protective structures, replacing dumb structures such as vehicle ...
(Date:6/24/2016)... 2016 Research and Markets has announced ... Diagnostic Tests" report to their offering. ... The World Market for Companion Diagnostics covers ... Market analysis in the report includes the following: ... Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
Breaking Medicine Technology: